MentalAId: an improved DenseNet model to assist scalable psychosis assessment
Abstract Background: The escalating mental health crisis during and post-COVID-19 underscores the urgent need for scalable, timely, cost-effective assessment solutions…
Abstract Background: The escalating mental health crisis during and post-COVID-19 underscores the urgent need for scalable, timely, cost-effective assessment solutions…
Abstract Background: Delta‐9‐tetrahydrocannabiphorol (Δ9‐THCP) is a potent phytocannabinoid found naturally in the cannabis plant in small quantities. This cannabinoid is…
Abstract Background: The association between cannabis and psychosis is established, but the role of underlying genetics is unclear. We used…
Abstract Cannabis-induced psychosis (CIP) is an increasingly acknowledged psychiatric phenomenon observed in vulnerable patients exposed to cannabis. This brief case…
Abstract There is increased risk of psychosis associated with cannabis use disorder and the interaction of THC with dopamine neurotransmission…
Abstract “Moon rock” cannabis is a type of new and highly potent preparation of cannabis, which is made of a…
Abstract Background: Cannabis (Δ9-THC) is the most commonly consumed illicit drug. The Agricultural Improvement Act of 2018 removed hemp, a…
Abstract Appraisals of the evidence on the relationship between cannabis use and psychosis are often biased by appraisers’ pre-existing views…
Abstract Background: Cannabis use disorder among young people with a first episode of psychosis contributes to relapse, hospitalization, and impaired…
Abstract Patients suffering from encephalitis may present psychiatric symptoms; however, the clinical relevance of anti-neuronal antibodies in patients experiencing a…